Kezar Life Sciences Inc (KZR)
7.55
+0.01
(+0.13%)
USD |
NASDAQ |
Nov 14, 16:00
7.55
0.00 (0.00%)
After-Hours: 20:00
Kezar Life Sciences Shareholders Equity (Quarterly): 150.68M for June 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 150.68M |
| March 31, 2024 | 169.12M |
| December 31, 2023 | 187.57M |
| September 30, 2023 | 215.99M |
| June 30, 2023 | 232.28M |
| March 31, 2023 | 252.49M |
| December 31, 2022 | 269.87M |
| September 30, 2022 | 283.19M |
| June 30, 2022 | 297.36M |
| March 31, 2022 | 232.32M |
| December 31, 2021 | 196.88M |
| September 30, 2021 | 119.48M |
| June 30, 2021 | 129.89M |
| March 31, 2021 | 140.64M |
| Date | Value |
|---|---|
| December 31, 2020 | 140.98M |
| September 30, 2020 | 150.32M |
| June 30, 2020 | 158.32M |
| March 31, 2020 | 122.65M |
| December 31, 2019 | 78.05M |
| September 30, 2019 | 86.50M |
| June 30, 2019 | 94.60M |
| March 31, 2019 | 102.14M |
| December 31, 2018 | 108.80M |
| September 30, 2018 | 114.13M |
| June 30, 2018 | 119.34M |
| March 31, 2018 | 47.44M |
| December 31, 2017 | -25.69M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
78.05M
Minimum
Dec 2019
297.36M
Maximum
Jun 2022
185.69M
Average
169.12M
Median
Mar 2024
Shareholders Equity (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | -0.617M |
| Palatin Technologies Inc | -0.1115M |
| iBio Inc | 21.32M |
| Theriva Biologics Inc | 27.65M |
| Oragenics Inc | 1.326M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 179.92M |
| Total Liabilities (Quarterly) | 29.24M |